Viewing Opinion | StockChase

Concordia International Corp (CXR-T) opinion on 2017-10-11

Last Price Recorded: 0.6800 on 2017-12-13

ON STOCKCHASE SINCE Mar 2014

Pharma & Healthcare
Pharma & Healthcare
DON'T BUY

Christine Poole
Concordia International Corp was $1.490 at time of opinion
Owned : No

She wouldn’t be buying this now, even though the stock price has come down dramatically from what it was a few years ago. This has only been public for about 4-5 years, and they’ve been buying assets. There is a lot of pricing pressure on the drugs they bought and paid a lot for. Has a lot of debt on their balance sheet. Debt to Enterprise EBITDA is over 11X. There is a big question as to how they are going to repay the debt when it comes due. Based on what they have now, it doesn’t seem sufficient.

OPTIMISTIC

All opinions for CXR-T (202)

8 BUY
3 BUY on WEAKNESS
64 COMMENT
52 DON'T BUY
11 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
9 PAST TOP PICK
13 SELL
1 SPECULATIVE BUY
19 TOP PICK
10 WAIT
8 WATCH
1 WEAK BUY
View All

More experts covering CXR-T

SAVE
Add CXR-T to Watch List

All opinions for CXR-T (202)

8 BUY
3 BUY on WEAKNESS
64 COMMENT
52 DON'T BUY
11 HOLD
1 PARTIAL BUY
2 PARTIAL SELL
9 PAST TOP PICK
13 SELL
1 SPECULATIVE BUY
19 TOP PICK
10 WAIT
8 WATCH
1 WEAK BUY
View All

More experts covering CXR-T

SAVE
Add CXR-T to Watch List

Last 60 Days Opinions

WATCH
4 weeks ago
BUY
1 month ago
SELL
1 month ago

No Comments.


You must be logged in to comment.

Successfully Saved Company